Gene · 2512
FTL: ferritin light chain
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FTL: ferritin light chain. Genes, record 2512. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2512
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P02792 | Ferritin light chain | 175 | 17 | Ensembl, GeneID, HGNC |
Source UniProt
Patents103
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46183 | P02792 | Espacenet |
| WO 2025248034 A1 | 2025-12-04 | 14 | P02792 | Espacenet |
| EP 4656659 A1 | 2025-12-03 | 14 | P02792 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5675 | P02792 | Espacenet |
| JP 2025081326 A | 2025-05-27 | 42 | P02792 | Espacenet |
| WO 2025081160 A1 | 2025-04-17 | 68 | P02792 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28641 | P02792 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5675 | P02792 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 28641 | P02792 | Espacenet |
| EP 4406544 A2 | 2024-07-31 | 13 | P02792 | Espacenet |
1 to 10 of 103
See all 103 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,436
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FTL papers | Newest fiscal year |
|---|---|---|---|
| P30ES006694 | Southwest Environmental Health Sciences Center | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 5 | 2025 |
| P42ES004940 | The DUST Center: Hazardous Dust in Drylands - Exposure, Health Impacts, and Mitigation | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 4 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| ZIAEY000281 | Clinical/molecular Studies In Families With Congenital Or Hereditary Cataracts | 4 | 2025 |
1 to 10 of 1,436Source NIH's project files
See all 1,436 nih grantsPapers2,666
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| rsRNA-28S-21 promotes endometrial cancer by regulating ferroptosis through the NSUN5-FTH1/FTL pathway. | Gene | 2026 | 42826770 | PubTator, text mining | PubMed |
| Artesunate alleviates cisplatin-induced nephrotoxicity by regulating tryptophan metabolism and inhibiting ferroptosis. | Front Pharmacol | 2026 | 42807112 | PubTator, text mining | PubMed |
| NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities. | Asia Pac J Clin Oncol | 2026 | 42802387 | PubTator, text mining | PubMed |
| Solasonine inhibits growth of gastric cancer by targeting FTL-mediated ferroptosis. | Bioorg Chem | 2026 | 42777387 | PubTator, text mining | PubMed |
| Exploratory single-nucleus transcriptomic analysis of endothelial heterogeneity and ferroptosis-related gene patterns in a human hepatocellular carcinoma sample. | Transl Oncol | 2026 | 42759407 | PubTator, text mining | PubMed |
| The emerging landscape of polymerase θ in tumor pathogenesis and precision treatment. | Biochem Biophys Res Commun | 2026 | 42748573 | PubTator, text mining | PubMed |
| Predicting diagnostic gene biomarkers associated with immune infiltration in patients with diabetes. | Braz J Med Biol Res | 2026 | 42715469 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics of Pyrimidine Salvage in HBV-Related HCC Reveals Prognostic and Immune Infiltration Features. | Biomol Ther (Seoul) | 2026 | 42676041 | PubTator, text mining | PubMed |
| Cross-cancer transcriptomic analysis reveals conserved developmental, ferroptosis, and immune remodeling modules in Wilms tumor and oral cancer. | Front Genet | 2026 | 42670482 | PubTator, text mining | PubMed |
| Iron Dyshomeostasis and Divergent Antigen Presentation Remodeling in Bronchiectasis: A Dual-Dataset Transcriptomic Analysis. | J Inflamm Res | 2026 | 42670432 | PubTator, text mining | PubMed |
1 to 10 of 2,666
See all 2,666 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2512
GET https://conductscience.org/api/genes/v1/2512/patents?page=2